Literature DB >> 20635917

Combination approaches to immunotherapy: the radiotherapy example.

Michael J Gough1, Marka R Crittenden.   

Abstract

The marquee cell of the immune response, the T lymphocyte, is exquisitely sensitive to ionizing radiation. Moreover, the majority of cells of the hematopoietic lineage, with their high turnover and radiation sensitivity, are effectively ablated by relatively low radiation doses, such that total-body irradiation is an effective immunosuppressive therapy. Despite and sometimes because of these facts, the immune system may underlie some portion of the therapeutic effects of radiation. In this review, we will discuss these processes, and go on to discuss current therapies combining radiation therapy with immunotherapy for the treatment of cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20635917     DOI: 10.2217/imt.09.64

Source DB:  PubMed          Journal:  Immunotherapy        ISSN: 1750-743X            Impact factor:   4.196


  15 in total

Review 1.  Development of immunotherapy in bladder cancer: present and future on targeting PD(L)1 and CTLA-4 pathways.

Authors:  Mathieu Rouanne; Mathieu Roumiguié; Nadine Houédé; Alexandra Masson-Lecomte; Pierre Colin; Géraldine Pignot; Stéphane Larré; Evanguelos Xylinas; Morgan Rouprêt; Yann Neuzillet
Journal:  World J Urol       Date:  2018-06-01       Impact factor: 4.226

2.  Comparative analysis of the effect of different radiotherapy regimes on lymphocyte and its subpopulations in breast cancer patients.

Authors:  C Yuan; Q Wang
Journal:  Clin Transl Oncol       Date:  2018-03-13       Impact factor: 3.405

Review 3.  Combining radiotherapy and cancer immunotherapy: a paradigm shift.

Authors:  Silvia C Formenti; Sandra Demaria
Journal:  J Natl Cancer Inst       Date:  2013-01-04       Impact factor: 13.506

Review 4.  Concepts of immunotherapy for glioma.

Authors:  Mira A Patel; Drew M Pardoll
Journal:  J Neurooncol       Date:  2015-06-13       Impact factor: 4.130

5.  Dose-dependent enhancement of T-lymphocyte priming and CTL lysis following ionizing radiation in an engineered model of oral cancer.

Authors:  Megan Morisada; Ellen C Moore; Rachel Hodge; Jay Friedman; Harrison A Cash; James W Hodge; James B Mitchell; Clint T Allen
Journal:  Oral Oncol       Date:  2017-06-10       Impact factor: 5.337

Review 6.  Strategies for optimizing the response of cancer and normal tissues to radiation.

Authors:  Everett J Moding; Michael B Kastan; David G Kirsch
Journal:  Nat Rev Drug Discov       Date:  2013-07       Impact factor: 84.694

7.  Radiation-induced autophagy potentiates immunotherapy of cancer via up-regulation of mannose 6-phosphate receptor on tumor cells in mice.

Authors:  Sungjune Kim; Rupal Ramakrishnan; Sergio Lavilla-Alonso; Prakash Chinnaiyan; Nikhil Rao; Erin Fowler; John Heine; Dmitry I Gabrilovich
Journal:  Cancer Immunol Immunother       Date:  2014-06-19       Impact factor: 6.968

8.  Stereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells in the Tumor Microenvironment.

Authors:  Yuki Muroyama; Thomas R Nirschl; Christina M Kochel; Zoila Lopez-Bujanda; Debebe Theodros; Wendy Mao; Maria A Carrera-Haro; Ali Ghasemzadeh; Ariel E Marciscano; Esteban Velarde; Ada J Tam; Christopher J Thoburn; Muniza Uddin; Alan K Meeker; Robert A Anders; Drew M Pardoll; Charles G Drake
Journal:  Cancer Immunol Res       Date:  2017-10-02       Impact factor: 11.151

Review 9.  Trial Watch: Anticancer radioimmunotherapy.

Authors:  Erika Vacchelli; Ilio Vitale; Eric Tartour; Alexander Eggermont; Catherine Sautès-Fridman; Jérôme Galon; Laurence Zitvogel; Guido Kroemer; Lorenzo Galluzzi
Journal:  Oncoimmunology       Date:  2013-07-03       Impact factor: 8.110

Review 10.  The future of glioblastoma therapy: synergism of standard of care and immunotherapy.

Authors:  Mira A Patel; Jennifer E Kim; Jacob Ruzevick; Gordon Li; Michael Lim
Journal:  Cancers (Basel)       Date:  2014-09-29       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.